Israel Englander’s Iovance Biotherapeutics IOVA Stock Holding History

Israel Englander’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-235,500	Closed	-$643K	–	6026
2025 Q4	$643K	Buy	+235,500	New	+$545K	﹤0.01%	4783
2025 Q2	–	Sell	-100,000	Closed	-$333K	–	6092
2025 Q1	$333K	Buy	+100,000	New	+$516K	﹤0.01%	5042
2024 Q3	–	Sell	-50,000	Closed	-$401K	–	6281
2024 Q2	$401K	Buy	+50,000	New	+$536K	﹤0.01%	4736
2024 Q1	–	Sell	-51,900	Closed	-$422K	–	6409
2023 Q4	$422K	Sell	51,900 -1,800	-3%	-$9.42K	﹤0.01%	4744
2023 Q3	$244K	Buy	+53,700	New	+$351K	﹤0.01%	5024
2022 Q3	–	Sell	-321,800	Closed	-$3.55M	–	7262
2022 Q2	$3.55M	Buy	321,800 +213,700	+198%	+$2.8M	﹤0.01%	3136
2022 Q1	$1.8M	Buy	+108,100	New	+$1.67M	﹤0.01%	3988
2021 Q3	–	Sell	-20,000	Closed	-$520K	–	7008
2021 Q2	$520K	Sell	20,000 -120,000	-86%	-$3.12M	﹤0.01%	5270
2021 Q1	$4.43M	Buy	140,000 +50,000	+56%	+$2.07M	﹤0.01%	2711
2020 Q4	$4.18M	Sell	90,000 -20,000	-18%	-$794K	﹤0.01%	2621
2020 Q3	$3.62K	Buy	+110,000	New	+$3.37M	﹤0.01%	2107
2020 Q1	–	Sell	-184,400	Closed	-$5.1M	–	4164
2019 Q4	$5.1M	Buy	+184,400	New	+$4.19M	0.01%	1917
2019 Q3	–	Sell	-139,500	Closed	-$3.42M	–	4358
2019 Q2	$3.42M	Buy	+139,500	New	+$2.1M	0.01%	2071

Other funds holding IOVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Israel Englander's IOVA Position: Q2 2026 in Review

Israel Englander reduced its Iovance Biotherapeutics (IOVA) stake by 9.4% in Q2 2026, selling an estimated $3.38M and leaving 8,525,919 shares worth $35.5M. The position accounts for 0.01% of the portfolio, ranked #1146.

Israel Englander first reported a position in IOVA in Q1 2015 and has held it in 39 quarters since. The position peaked at $39.5M in Q1 2022. 289 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

Israel Englander held 8,525,919 shares of Iovance Biotherapeutics worth $35.5M as of Q2 2026.
Israel Englander sold 888,373 Iovance Biotherapeutics shares in Q2 2026, an estimated $3.38M.
Iovance Biotherapeutics made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1146 holding.
Israel Englander first reported a position in Iovance Biotherapeutics in Q1 2015 and has held it in 39 quarters since.
Israel Englander's Iovance Biotherapeutics position peaked at $39.5M in Q1 2022.
289 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.